Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).

Reviews on recent clinical trials

Volumn 1, Issue 1, 2006, Pages 1-13

  Metro, Giulio ^a   Finocchiaro, Giovanna ^a   Toschi, Luca ^a   Bartolini, Stefania ^a   Magrini, Elisabetta ^a   Cancellieri, Alessandra ^a   Trisolini, Rocco ^a   Castaldini, Luciano ^a   Tallini, Giovanni ^a   Crino, Lucio ^a   Cappuzzo, Federico ^a  

^a BELLARIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; MONOCLONAL ANTIBODY; QUINAZOLINE DERIVATIVE; TRASTUZUMAB;

DRUG ANTAGONISM; DRUG EFFECT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; ONCOGENE RAS; REVIEW; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENES, RAS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 43549105662     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488706775246157     Document Type: Review

References (97)